Metformin Dose for Weight Loss: What the Evidence Actually Shows

Metformin is not FDA-approved for weight loss, but off-label studies most often use 1,000–2,000 mg per day, with stronger effects seen above 1,500 mg daily for at least six months. Providers usually start low and increase slowly to limit stomach side effects. Average weight loss is modest, about 2–6% of body weight, and individual results vary.[1][2][3]

Quick facts: metformin dosing for weight loss

Metformin is the international nonproprietary name for metformin hydrochloride, a biguanide drug sold under brand names such as Glucophage, Glucophage XR, Fortamet, Glumetza, and Riomet. It is FDA-approved to help manage blood sugar in type 2 diabetes, but it is not FDA-approved as a weight-loss drug.[1]

When metformin is studied for weight management, it is usually used off-label. Many trials and clinical reviews describe total daily doses in the 1,000–2,000 mg range, reached gradually to reduce gastrointestinal side effects such as nausea, diarrhea, and stomach cramping.[1][2][3]

Is metformin actually used for weight loss?

Yes, metformin is sometimes prescribed off-label for weight management, especially when insulin resistance, prediabetes, polycystic ovary syndrome (PCOS), type 2 diabetes, or antipsychotic-associated weight gain is part of the picture. Off-label means the FDA has not approved the medication for that use, even if clinicians may consider it based on evidence and a patient’s risk profile.[1][2][7][8]

The Diabetes Prevention Program found that metformin reduced progression to type 2 diabetes in adults at high risk, and weight change appeared to explain part of that benefit. In long-term follow-up, people assigned to metformin had modest but durable weight loss, while side effects were mainly gastrointestinal and safety monitoring remained important.[2][3]

Metformin has also been studied in PCOS and antipsychotic-induced weight gain. These studies suggest some people may lose weight or gain less weight, but effects are not the same for everyone, and side effects such as nausea, diarrhea, and low vitamin B12 over time still need attention.[6][7][8]

What dose of metformin is used for weight loss?

There is no FDA-approved metformin dose for weight loss. In off-label studies, many total daily doses fall between 1,000 and 2,000 mg per day, but the right dose depends on the reason it is being used, kidney function, tolerability, other medications, and clinician judgment.[1][2][3]

Typical starting dose

Metformin labels describe low starting doses for blood-sugar treatment, often with food to reduce stomach upset. For off-label weight management, clinicians commonly use the same “start low, go slow” idea, but this should not be treated as a personal dosing plan.[1]

Titration schedule

Titration means raising the dose step by step. Slow titration may reduce diarrhea, nausea, gas, and stomach pain, but side effects can still happen and may lead some people to stop treatment.[1][4]

Effective dose range in studies

In the Diabetes Prevention Program and its follow-up, metformin was studied at a total daily dose of 1,700 mg in adults at high risk for diabetes. Long-term data showed modest average weight loss with continued use, along with the need to monitor safety issues such as GI symptoms and vitamin B12 deficiency.[2][3][6]

Maximum dose

FDA labeling lists maximum adult doses for diabetes treatment that differ by formulation, including higher limits for some immediate-release products than for many extended-release products. These are label limits for glucose management, not recommended weight-loss targets, and higher doses can raise the chance of side effects.[1]

Immediate-release vs extended-release: which is better for weight loss?

Immediate-release metformin and extended-release metformin both contain metformin hydrochloride. There is no strong evidence that one form reliably causes more weight loss than the other, but ER/XR forms may be easier on the stomach for some people, which can help them stay on therapy if a clinician recommends it.[1][4]

The main difference is how the drug is released and how often it is taken for approved diabetes care. Since stomach side effects are common, tolerability can matter as much as the expected weight effect, which is usually modest even when metformin works.[1][2][4]

How long does metformin take to work for weight loss?

With metformin, weight change is usually gradual. In clinical studies, meaningful averages are often reported over 6 to 12 months, not days or weeks. Some people notice appetite or weight changes sooner, but others do not lose weight or stop because of side effects.[2][3]

Longer-term DPP follow-up found that people who kept taking metformin had modest weight loss that could persist over time. That benefit must be balanced with ongoing monitoring for gastrointestinal effects, kidney safety, and vitamin B12 deficiency.[3][6]

How much weight can you expect to lose on metformin?

Average weight loss with metformin is modest. Across studies, many people lose about 2–6% of body weight, while some lose more, some lose less, and some do not lose weight. Individual results vary, and side effects can limit the dose or duration of treatment.[2][3][7][8]

Results at 3, 6, and 12 months

Short-term weight changes can be small. In DPP-related data, the more useful signal came over months and years, with metformin producing less average weight gain or modest weight loss compared with placebo. Stomach side effects were more common with metformin than placebo, especially early in treatment.[2][3]

Who tends to lose the most

People with insulin resistance, prediabetes, higher BMI, PCOS, or antipsychotic-associated weight gain are often the groups studied. These groups may be more likely to benefit than someone without these factors, but metformin is still not a guaranteed weight-loss medication and is not FDA-approved for weight loss.[1][2][7][8]

How does metformin cause weight loss?

Metformin lowers liver glucose production and improves insulin sensitivity, which may reduce high insulin levels in some people. It may also affect appetite signals and the gut microbiome, but the exact weight-loss pathway is not fully settled.[1][9]

These mechanisms may help explain why metformin is studied in prediabetes, insulin resistance, PCOS, and antipsychotic-induced weight gain. The same medication can also cause GI symptoms, and rare but serious lactic acidosis risk is why kidney function and illness risk matter.[1][5][7][8]

What are the side effects at weight-loss doses?

Metformin side effects can happen at any dose, including the 1,000–2,000 mg per day range often used in studies. The most common problems are gastrointestinal, while rare serious risks depend more on kidney function, acute illness, alcohol use, and other health factors than on weight-loss goals.[1][5]

Common GI side effects

Nausea, diarrhea, gas, stomach pain, and reduced appetite are common. Taking metformin with food and using gradual titration are label-supported ways clinicians try to improve tolerability, but some people still cannot tolerate it.[1][4]

Lactic acidosis and the black-box warning

Metformin carries a boxed warning for lactic acidosis, a rare but life-threatening buildup of lactic acid. Risk is higher with significant renal impairment, dehydration, severe infection, low oxygen states, liver disease, heavy alcohol use, or acute illness, so clinicians screen for these risks before and during treatment.[1][5]

Vitamin B12 monitoring

Long-term metformin use can lower vitamin B12 levels. The DPP Outcomes Study found biochemical B12 deficiency was more common in the metformin group than placebo, so periodic B12 checks may be considered, especially if anemia, neuropathy symptoms, or long-term use are present.[6]

Who should not take metformin for weight loss?

Metformin may not be appropriate for people with certain kidney problems, because FDA labeling uses eGFR thresholds to guide use. It is contraindicated when eGFR is below 30 mL/min/1.73 m², and starting metformin is not recommended when eGFR is 30–45 mL/min/1.73 m².[1][5]

People with heavy alcohol use, severe liver disease, unstable heart or lung disease, dehydration, severe infection, or upcoming contrast imaging may need special review or temporary medication changes. These situations can raise lactic acidosis risk, and a clinician should weigh any possible weight benefit against those risks.[1][5]

Pregnancy, breastfeeding, eating disorder history, low body weight, complex medication lists, and symptoms of B12 deficiency also deserve clinician review. Metformin may be appropriate for some people in these groups for specific medical reasons, but not as casual weight-loss use.[1][6]

How does metformin compare to GLP-1 medications for weight loss?

Metformin and GLP-1 medications are different tools. Metformin is FDA-approved for type 2 diabetes and is used off-label for weight management, while Wegovy (semaglutide, a GLP-1 receptor agonist) and Zepbound (tirzepatide, a GIP/GLP-1 receptor agonist) are FDA-approved for chronic weight management in eligible adults, with label-defined risks and contraindications.[1][10][11]

Semaglutide is also sold as Ozempic for type 2 diabetes, and tirzepatide is sold as Mounjaro for type 2 diabetes. Compounded semaglutide and compounded tirzepatide may be dispensed by licensed 503A pharmacies when legally permitted and prescribed for an individual patient, but compounded versions are not FDA-approved products and do not go through FDA premarket review for safety, effectiveness, or quality.[12]

How do I get metformin for weight loss?

To discuss metformin for weight loss, start with a licensed clinician who can review your goals, medical history, kidney function, B12 risk, alcohol use, and other medications. Because metformin is not FDA-approved for weight loss, a prescription for weight management is off-label and should be based on a clear clinical reason.[1][5][6]

A clinician may also compare metformin with FDA-approved weight-management medications, lifestyle treatment, or no medication. If GLP-1 options are discussed, brand-name and compounded GLP-1s should be reviewed carefully: 503A compounding pharmacies prepare patient-specific prescriptions when allowed, but compounded products are not FDA-approved and are not FDA-reviewed for safety, effectiveness, or quality before dispensing.[10][11][12]

Chia is one telehealth option where eligible patients can complete a clinician-reviewed evaluation for weight-management care, including discussion of prescription options when appropriate. The best path depends on your health history, labs, medication risks, preferences, and access.

Frequently asked questions

Keep reading

Metabolic Health

Metformin Side Effects: What to Expect and How to Manage Them

Metabolic Health

The Best Diet for Metabolic Syndrome: An Evidence-Based Guide

GLP-1 & Weight Loss

Microdosing GLP-1s: What It Means, Who It's For, and What the Evidence Says